Unprecedented improvement of ovarian cancer survival in BRCA-positive patients
The drug olaparib delays the recurrence of advanced ovarian cancer in woman who carry the BRCA gene.
Read more about 'Unprecedented improvement of ovarian cancer survival in BRCA-positive patients'...
Posted in BRCA; Posted 8 years ago by Andreas Obermair
Recent Posts
- Self-collection keeps Australia on path to cervical cancer elimination
- Will you join me for the next Cherish trek in April 2027?
- Elected to International Gynecologic Cancer Society Presidency
- Our 2026 Cherish Challenge: Ten Peaks. Ten Reasons
- Managing Adnexal Masses in Older Women: Striking the Right Balance